• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS / RESPIRONICS INC. PHILIPS DREAMSTATION CPAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS / RESPIRONICS INC. PHILIPS DREAMSTATION CPAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Device Problems Nonstandard Device (1420); Protective Measures Problem (3015)
Patient Problems Cancer (3262); Lymphoma (3263)
Event Date 07/15/2021
Event Type  Injury  
Event Description
I have a dreamstation philips cpap, recalled in june 2021, replaced in october 2021.Your site says: https://www.Fda.Gov/medical-devices/safety-communications/update-certain-philips-respironics-ventilators-bipap-machines-and-cpap-machines-recalled-due#repairedreplaced repaired and replaced bipap or cpap machines recommendations for people who use bipap or cpap machines replaced by philips and their caregivers be aware that during the manufacturing facility inspection, the fda obtained additional information, not previously available to the fda, regarding the silicone-based foam used in a similar device marketed outside the u.S., which failed one safety test for the release of certain chemicals of concern, called volatile organic compounds (vocs).Similar testing provided by philips to the fda on devices authorized for marketing in the u.S.Had demonstrated acceptable results.The fda has requested that philips retain an independent laboratory to perform additional testing to determine what, if any, potential safety risks may be posed to patients by the silicone-based foam.At this time, the fda does not have sufficient information to conclude whether the silicone-based foam being used in the repaired devices poses any risk to patients in the u.S.Question: what is the status of the "additional testing"? i came down with lymphoma (blood cancer) in (b)(6) 2021, followed by kidney cancer in (b)(6) 2022.I do not trust the philips replacement and have been using my older cpap.Reference report mw5116203.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHILIPS DREAMSTATION CPAP
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS / RESPIRONICS INC.
MDR Report Key16663277
MDR Text Key312725134
Report NumberMW5116202
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/31/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age71 YR
Patient SexMale
Patient Weight98 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-